Project Grant HT9425261E124
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $794,148 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with a completion date of August 31, 2028. The award supports the development and implementation of a mouse model designed to investigate differential therapeutic responses and mechanisms of tumor recurrence in glioblastoma. This research will...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $1.2M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research evaluating disparities and improving quality of prostate cancer detection for veterans through imaging. The research will be conducted at Northwestern's Evanston, Illinois campus and is designed to...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $200,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2025, with a completion date of June 30, 2027. The award funds research to elucidate the neural basis of hallucinations in Parkinson's disease, with work performed at the university's Evanston, Illinois campus. This research aligns with the program's mission...
- Federal Grant Award Summary The University of Chicago received a $869,193 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award funds research to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF), a basic biomedical research initiative aligned with the program's objective to transform healthcare for service members and the American public through...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects has received a $1.396 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2029. The award supports clinical validation of a plasma circulating tumor DNA (ctDNA) assay for diffuse midline glioma (DMG) diagnosis and surveillance. This research initiative contributes to the DHA's...
- Federal Project Grant Award Summary New York University School of Medicine received a $1.67M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2026, with completion targeted for September 29, 2029. The award funds research to identify and characterize pathways that prevent the emergence of drug-tolerant persisters—a critical challenge in antimicrobial and cancer therapeutic resistance. This...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $699,751 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2026, with a completion date of April 30, 2029. The award funds research to unveil mechanisms and develop innovative therapeutic interventions targeting ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers. This research initiative represents the DHA's...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $1.7 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year performance period running from July 1, 2026, through June 30, 2029. The award funds research focused on targeted disruption of the ARP300 enhanceosome in prostate cancer using domain-alteration chimeras (DALTACs), representing...